Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000038777-15-000089
Filing Date
2015-02-09
Accepted
2015-02-06 19:20:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 cell14a2.htm SC 13G/A 222154
  Complete submission text file 0000038777-15-000089.txt   223963
Mailing Address FRANKLIN RESOURCES INC ONE FRANKLIN PARKWAY SAN MATEO CA 94403
Business Address ONE FRANKLIN PARKWAY BUILDING 920 SAN MATEO CA 94403 650-312-2000
FRANKLIN RESOURCES INC (Filed by) CIK: 0000038777 (see all company filings)

EIN.: 132670991 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 15586361
SIC: 2835 In Vitro & In Vivo Diagnostic Substances